Michael Borenstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Borenstein has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Julian Piers Thomas Higgins
University of Bristol
4 shared publications - Larry Vernon Hedges
Northwestern University, Evanston, IL, USA
4 shared publications - Hannah R. Rothstein
Baruch College-City University of New York
2 shared publications A. Loebel
Hillside Hospital, Research Department, P.O. Box 38, Glen Oaks, NY 11004, U.S.A.
1 shared publicationD. Jody
Hillside Hospital, Research Department, P.O. Box 38, Glen Oaks, NY 11004, U.S.A.
1 shared publication- Daniel J. Canney
Department of Pharmaceuticals Sciences, Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, United States
1 shared publication
Latest Publications
- 12 January 2024
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 138 (2) , 376-378
Systematic Reviews and Meta-Analyses in Regional Anesthesia and Pain Medicine
- 12 January 2024
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 138 (2) , 376-378
Systematic Reviews and Meta-Analyses in Regional Anesthesia and Pain Medicine
- 1 January 2024
- Published by Instats
Meta-Analysis: An Advanced Course
This four-day workshop covers advanced topics in meta-analysis, including how to quantify and explain heterogeneity in effects across studies. Participants will learn how to use subgroups analysis and meta-regression while covering key topics such as publication bias, complex data sets, and limitations of the random-effects model. Each topic will be introduced at the conceptual level, followed by worked examples and exercises so that participants will feel comfortable performing these analyses on their own. All sessions include time for an extensive discussion.
- 1 January 2024
- Published by Instats
Meta-Analysis: An Advanced Course
This four-day workshop covers advanced topics in meta-analysis, including how to quantify and explain heterogeneity in effects across studies. Participants will learn how to use subgroups analysis and meta-regression while covering key topics such as publication bias, complex data sets, and limitations of the random-effects model. Each topic will be introduced at the conceptual level, followed by worked examples and exercises so that participants will feel comfortable performing these analyses on their own. All sessions include time for an extensive discussion.
- 1 January 2024
- Published by Instats
Meta-Analysis: An Introductory Course
This four-day workshop provides the knowledge and skills needed to start conducting and reporting the results of meta-analyses. An emphasis is placed on the two primary types of meta-analysis: fixed-effects versus random-effects models. Each topic will be introduced at the conceptual level, followed by worked examples and exercises so that participants will feel comfortable performing these analyses on their own. All sessions include time for an extensive discussion.
- 1 January 2024
- Published by Instats
Meta-Analysis: An Introductory Course
This four-day workshop provides the knowledge and skills needed to start conducting and reporting the results of meta-analyses. An emphasis is placed on the two primary types of meta-analysis: fixed-effects versus random-effects models. Each topic will be introduced at the conceptual level, followed by worked examples and exercises so that participants will feel comfortable performing these analyses on their own. All sessions include time for an extensive discussion.
- Top Cited PapersOpen Access
- 28 November 2023
- Published by Elsevier in Integrative Medicine Research
- Vol. 12 (4) , 101014
How to understand and report heterogeneity in a meta-analysis: The difference between I-squared and prediction intervals
- 28 November 2023
- Published by Elsevier in Integrative Medicine Research
- Vol. 12 (4) , 101014
Top Cited PapersOpen AccessHow to understand and report heterogeneity in a meta-analysis: The difference between I-squared and prediction intervals
- Top Cited Papers
- 8 November 2023
- Published by Wiley in Research Synthesis Methods
- Vol. 15 (2) , 354-368
Avoiding common mistakes in meta‐analysis: Understanding the distinct roles of Q, I‐squared, tau‐squared, and the prediction interval in reporting heterogeneity
In any meta‐analysis, it is critically important to report the dispersion in effects as well as the mean effect. If an intervention has a moderate clinical impact on average we also need to know if the impact is moderate for all relevant populations, or if it varies from trivial in some to major in others. Or indeed, if the intervention is beneficial in some cases but harmful in others. Researchers typically report a series of statistics such as the Q‐value, the p‐value, and I2, which are intended to address this issue. Often, they use these statistics to classify the heterogeneity as being low, moderate, or high and then use these classifications when considering the potential utility of the intervention. While this practice is ubiquitous, it is nevertheless incorrect. The statistics mentioned above do not actually tell us how much the effect size varies. Classifications of heterogeneity based on these statistics are uninformative at best, and often misleading. My goal in this paper is to explain what these statistics do tell us, and that none of them tells us how much the effect size varies. Then I will introduce the prediction interval, the statistic that does tell us how much the effect size varies, and that addresses the question we have in mind when we ask about heterogeneity. This paper is adapted from a chapter in “Common Mistakes in Meta‐Analysis and How to Avoid Them.” A free PDF of the book is available at https://www.Meta-Analysis.com/rsm.
- 8 November 2023
- Published by Wiley in Research Synthesis Methods
- Vol. 15 (2) , 354-368
Top Cited PapersAvoiding common mistakes in meta‐analysis: Understanding the distinct roles of Q, I‐squared, tau‐squared, and the prediction interval in reporting heterogeneity
In any meta‐analysis, it is critically important to report the dispersion in effects as well as the mean effect. If an intervention has a moderate clinical impact on average we also need to know if the impact is moderate for all relevant populations, or if it varies from trivial in some to major in others. Or indeed, if the intervention is beneficial in some cases but harmful in others. Researchers typically report a series of statistics such as the Q‐value, the p‐value, and I2, which are intended to address this issue. Often, they use these statistics to classify the heterogeneity as being low, moderate, or high and then use these classifications when considering the potential utility of the intervention. While this practice is ubiquitous, it is nevertheless incorrect. The statistics mentioned above do not actually tell us how much the effect size varies. Classifications of heterogeneity based on these statistics are uninformative at best, and often misleading. My goal in this paper is to explain what these statistics do tell us, and that none of them tells us how much the effect size varies. Then I will introduce the prediction interval, the statistic that does tell us how much the effect size varies, and that addresses the question we have in mind when we ask about heterogeneity. This paper is adapted from a chapter in “Common Mistakes in Meta‐Analysis and How to Avoid Them.” A free PDF of the book is available at https://www.Meta-Analysis.com/rsm.
- Top Cited Papers
- 9 October 2022
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 152, 281-284
In a meta-analysis, the I-squared statistic does not tell us how much the effect size varies
- 9 October 2022
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 152, 281-284
Top Cited PapersIn a meta-analysis, the I-squared statistic does not tell us how much the effect size varies
- Top Cited PapersOpen Access
- 1 April 2020
- Published by Elsevier in Journal of Physiotherapy
- Vol. 66 (2) , 135-139
Research Note: In a meta-analysis, the I index does not tell us how much the effect size varies across studies
- 1 April 2020
- Published by Elsevier in Journal of Physiotherapy
- Vol. 66 (2) , 135-139
Top Cited PapersOpen AccessResearch Note: In a meta-analysis, the I index does not tell us how much the effect size varies across studies
- Top Cited Papers
- 6 January 2017
- Published by Wiley in Research Synthesis Methods
- Vol. 8 (1) , 5-18
Basics of meta‐analysis: I2 is not an absolute measure of heterogeneity
When we speak about heterogeneity in a meta‐analysis, our intent is usually to understand the substantive implications of the heterogeneity. If an intervention yields a mean effect size of 50 points, we want to know if the effect size in different populations varies from 40 to 60, or from 10 to 90, because this speaks to the potential utility of the intervention. While there is a common belief that the I2 statistic provides this information, it actually does not. In this example, if we are told that I2 is 50%, we have no way of knowing if the effects range from 40 to 60, or from 10 to 90, or across some other range. Rather, if we want to communicate the predicted range of effects, then we should simply report this range. This gives readers the information they think is being captured by I2 and does so in a way that is concise and unambiguous. Copyright © 2017 John Wiley & Sons, Ltd.
- 6 January 2017
- Published by Wiley in Research Synthesis Methods
- Vol. 8 (1) , 5-18
Top Cited PapersBasics of meta‐analysis: I2 is not an absolute measure of heterogeneity
When we speak about heterogeneity in a meta‐analysis, our intent is usually to understand the substantive implications of the heterogeneity. If an intervention yields a mean effect size of 50 points, we want to know if the effect size in different populations varies from 40 to 60, or from 10 to 90, because this speaks to the potential utility of the intervention. While there is a common belief that the I2 statistic provides this information, it actually does not. In this example, if we are told that I2 is 50%, we have no way of knowing if the effects range from 40 to 60, or from 10 to 90, or across some other range. Rather, if we want to communicate the predicted range of effects, then we should simply report this range. This gives readers the information they think is being captured by I2 and does so in a way that is concise and unambiguous. Copyright © 2017 John Wiley & Sons, Ltd.
- 1 August 2014
- Published by American Educational Research Association (AERA) in Journal of Educational and Behavioral Statistics
- Vol. 39 (4) , 257-281
Conditional Optimal Design in Three- and Four-Level Experiments
The precision of estimates of treatment effects in multilevel experiments depends on the sample sizes chosen at each level. It is often desirable to choose sample sizes at each level to obtain the smallest variance for a fixed total cost, that is, to obtain optimal sample allocation. This article extends previous results on optimal allocation to four-level cluster randomized designs and randomized block designs. It also introduces the idea of constrained optimal allocation, where the sample size at one or more levels is fixed by considerations other than cost or sampling variation. Explicit formulas are given for constrained optimal allocation in three- and four-level designs.
- 1 August 2014
- Published by American Educational Research Association (AERA) in Journal of Educational and Behavioral Statistics
- Vol. 39 (4) , 257-281
Conditional Optimal Design in Three- and Four-Level Experiments
The precision of estimates of treatment effects in multilevel experiments depends on the sample sizes chosen at each level. It is often desirable to choose sample sizes at each level to obtain the smallest variance for a fixed total cost, that is, to obtain optimal sample allocation. This article extends previous results on optimal allocation to four-level cluster randomized designs and randomized block designs. It also introduces the idea of constrained optimal allocation, where the sample size at one or more levels is fixed by considerations other than cost or sampling variation. Explicit formulas are given for constrained optimal allocation in three- and four-level designs.
- Top Cited Papers
- 13 March 2013
- Published by Springer Nature in Prevention Science
- Vol. 14 (2) , 134-143
Meta-Analysis and Subgroups
Subgroup analysis is the process of comparing a treatment effect for two or more variants of an intervention—to ask, for example, if an intervention’s impact is affected by the setting (school versus community), by the delivery agent (outside facilitator versus regular classroom teacher), by the quality of delivery, or if the long-term effect differs from the short-term effect. While large-scale studies often employ subgroup analyses, these analyses cannot generally be performed for small-scale studies, since these typically include a homogeneous population and only one variant of the intervention. This limitation can be bypassed by using meta-analysis. Meta-analysis allows the researcher to compare the treatment effect in different subgroups, even if these subgroups appear in separate studies. We discuss several statistical issues related to this procedure, including the selection of a statistical model and statistical power for the comparison. To illustrate these points, we use the example of a meta-analysis of obesity prevention.
- 13 March 2013
- Published by Springer Nature in Prevention Science
- Vol. 14 (2) , 134-143
Top Cited PapersMeta-Analysis and Subgroups
Subgroup analysis is the process of comparing a treatment effect for two or more variants of an intervention—to ask, for example, if an intervention’s impact is affected by the setting (school versus community), by the delivery agent (outside facilitator versus regular classroom teacher), by the quality of delivery, or if the long-term effect differs from the short-term effect. While large-scale studies often employ subgroup analyses, these analyses cannot generally be performed for small-scale studies, since these typically include a homogeneous population and only one variant of the intervention. This limitation can be bypassed by using meta-analysis. Meta-analysis allows the researcher to compare the treatment effect in different subgroups, even if these subgroups appear in separate studies. We discuss several statistical issues related to this procedure, including the selection of a statistical model and statistical power for the comparison. To illustrate these points, we use the example of a meta-analysis of obesity prevention.